News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Migami, Inc. Profits $1.5 Million from Peptide Sublicense


3/19/2008 11:22:13 AM

LOS ANGELES--(BUSINESS WIRE)--Migami, Inc. (OTCBB:MIGA) has agreed to sublicense its rights to several peptide molecules related to alpha-melanocyte-stimulating hormones to Migami Korea, Ltd. (MKL) for $1.5 million and anticipated royalties. The sublicense agreement specifies the territory as South Korea, and the expiration of the patents will effectively terminate the contract.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES